The study led by the University of California in San Diego identified the specific brain circuit responsible for placebo-induced pain relief.
Published on April 17, 2026, the research demonstrates that expectation of pain relief activates a biological mechanism involving the release of endorphins.
This circuit connects the cerebral cortex —associated with thought and decision-making— to the brainstem and spinal cord.
The pathway allows relief signals to descend to areas where pain is processed, reducing intensity before conscious perception.
A key node in this circuit is the ventrolateral periaqueductal gray, which regulates endorphin release and acts as a pain control center.
Researchers trained mice to associate certain stimuli with pain reduction, observing real analgesic responses driven by expectation alone.
The team, headed by Matthew Banghart, mapped the full placebo pathway for the first time using adapted human experimental models.
When the expectancy-aligned neural pathway was stimulated, analgesic effects appeared even without expectation of relief.
The pontine nucleus, a target of this pathway, contains abundant opioid receptors, supporting its role in pain modulation.
These findings confirm that placebo analgesia is a concrete neurobiological process, not merely psychological.
What does this mean for future pain treatment?
The discovery could inform drug-free therapies targeting this neural circuit to enhance natural pain relief mechanisms.
How was the placebo effect studied in this research?
Scientists used mouse models trained to expect pain reduction, then measured real-time neural activity and behavioral responses to confirm endogenous analgesia.